Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Active not recruiting 2Terminated 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Polycystic Ovary Syndrome 3Leukoplakia, Oral 2Insulin Resistance 2Glioblastoma 2Erythroplasia 2Endometrial Neoplasms 2Endometrial Hyperplasia 2Carcinoma, Intraductal, Noninfiltrating 2Urothelial Cancer 1Squamous Cell Carcinoma of Head and Neck 1Smoldering Multiple Myeloma 1Prostatic Neoplasms 1Prediabetic State 1Pancreatic Adenocarcinoma 1Mouth Neoplasms 1Monoclonal Gammopathy of Undetermined Significance 1Metabolic Diseases 1Lung Neoplasms 1Infertility 1Hyperplasia 1Diabetes Mellitus 1Breast Neoplasms 1Breast Carcinoma In Situ 1Advanced Solid Malignancies 1Advanced Pancreatic Cancer 1

Interventions

Metformin 2Spectrometry, Fluorescence 1Specimen Handling 1Optical Imaging 1Molecular Diagnostic Techniques 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Erythroplasia × Metformin × Clear all
NCT05237960 2026-04-20

Metformin for the Prevention of Oral Cancer in Patients With Oral Leukoplakia or Erythroplakia

University of Arizona

Phase 2 Active not recruiting
34 enrolled
Head & Neck

Erythroplasia, Leukoplakia, Oral

NCT02581137 2026-04-13

Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion

National Cancer Institute (NCI)

Phase 2 Active not recruiting
26 enrolled 10 charts
Head & Neck

Erythroplasia, Hyperplasia, Leukoplakia, Oral, Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡